期刊文献+

中医药从双层面治疗非酒精性脂肪肝的机制研究进展 被引量:8

Treatment of Nonalcoholic Fatty Liver Disease Using TCM from Double Layers
原文传递
导出
摘要 非酒精性脂肪肝的发病率不断升高,已成为我国重要的慢性肝病之一,其发病机制以胰岛素抵抗与氧化应激为核心,目前西医对于NAFLD尚无具有确切临床疗效的药物,中医在辨证论治的基础上对于NAFLD具有良好的治疗效果。基于近年中医药治疗NAFLD的临床与实验研究,归纳中医药单味药活性成分从IR与OS双层面治疗NAFLD的研究进展。 The incidence of nonalcoholic fatty liver disease continues to increase.Nowadays,nonalcoholic fatty liver disease has become one of the most important chronic liver diseases in our country and its pathogenesis is related to insulin resistance and oxidative stress.There are no drugs to treat NAFLD in current western medicin.TCM syndrome differentiation has a very good effect on NAFLD.To study the clinical and experimental research of Chinese medicine treatment of NAFLD in recent years,it summarizes the research of the active ingredients of Chinese medicine treating NAFLD from the double layers of IR and OS.
作者 穆杰 王雪茜 王庆国 程发峰 朱文翔 翟昌明 马重阳 MU Jie;WANG Xueqian;WANG Qingguo;CHNEG Facheng;ZI-IU Wenxiang;ZHAI Changming;MA Chongyang(Beijing University of Chinese Medicine,Beijing 100029,China)
出处 《辽宁中医杂志》 CAS 2018年第12期2681-2684,共4页 Liaoning Journal of Traditional Chinese Medicine
基金 国家自然科学基金面上项目(81774122)
关键词 中药活性成分 非酒精性脂肪肝 胰岛素抵抗 氧化应激 active components of Chinese medicine nonalcoholic fatty liver disease insulin resistance oxidative stress
  • 相关文献

参考文献5

二级参考文献29

共引文献148

同被引文献88

引证文献8

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部